[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$xph Graphic](https://lunarcrush.com/gi/w:26/t:$xph.png) $xph

FDA approves Merck Animal Health's BRAVECTO QUANTUM, driving positive sentiment and creator engagement. Creators are up XXXXX% from the previous week and Mentions hit an all time high.

### About $xph
XPH is a financial symbol, likely representing a healthcare or pharmaceutical company.  

### Engagements: XXXXX [#](/topic/$xph/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$xph/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$xph/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXXX +33%  
**1-Year High**: XXXXX on 2025-06-23  
**1-Year Low**: XXX on 2025-06-29  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$xph/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$xph/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$xph/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +18%  
**1-Year High**: XXX on 2025-07-12  
**1-Year Low**: XX on 2025-06-29  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: X [#](/topic/$xph/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$xph/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$xph/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $xph in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X no change  
**1 Month**: XX -XXXX%  
**1-Year High**: X on 2025-05-20  
**1-Year Low**: X on 2025-05-04  

The most influential creators that mention $xph in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$xph/100)
  
  
### Sentiment: XX% [#](/topic/$xph/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$xph/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$xph/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-05-11  
**1-Year Low**: XX% on 2025-05-14  

**Most Supportive Themes**
- **Positive Clinical Trial Results & FDA Approvals:** (25%) Positive news and developments in the healthcare and biotech industries, including FDA approvals, positive trial results, and research breakthroughs.
  
**Most Critical Themes**
- **Regulatory Setbacks & Trial Failures:** (6%)  Concerns or negative developments related to specific companies or clinical trials within the healthcare sector.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XXX      | X% |
  


**Top assets mentioned**
In the posts about $xph in the last XX hours

[Bitcoin Incognito (XBI)](/topic/$xbi)
[Arcana Network (XAR)](/topic/$xar)
[Spacemesh (SMH)](/topic/$smh)
[Robonomics Network (XRT)](/topic/$xrt)
[Barclays PLC (BCS)](/topic/$bcs)
[Embraer S.A. (ERJ)](/topic/$erj)
[Barclays PLC (BCS)](/topic/barclays-plc)
[Biogen Inc (BIIB)](/topic/$biib)
[Biogen Inc (BIIB)](/topic/biogen-inc)
[Cytokinetics Inc. (CYTK)](/topic/$cytk)

**Top topics mentioned**
In the posts about $xph in the last XX hours

[$xbi](/topic/$xbi), [$pph](/topic/$pph), [$ibb](/topic/$ibb), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [approved](/topic/approved), [coins ai](/topic/coins-ai), [$zvra](/topic/$zvra), [combo](/topic/combo), [longterm](/topic/longterm), [coins layer 1](/topic/coins-layer-1), [coins defi](/topic/coins-defi), [coins solana ecosystem](/topic/coins-solana-ecosystem), [coins arbitrum](/topic/coins-arbitrum), [$xsd](/topic/$xsd), [$xar](/topic/$xar), [$rckt](/topic/$rckt), [$imab](/topic/$imab), [$okyo](/topic/$okyo), [$sxtp](/topic/$sxtp), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [coins made in usa](/topic/coins-made-in-usa), [$pej](/topic/$pej), [$ppa](/topic/$ppa), [$xlf](/topic/$xlf), [$iwm](/topic/$iwm), [$kie](/topic/$kie), [investment](/topic/investment), [$smh](/topic/$smh), [coins dot](/topic/coins-dot), [$xrt](/topic/$xrt), [coins depin](/topic/coins-depin), [$batt](/topic/$batt), [$shld](/topic/$shld), [$bcs](/topic/$bcs), [$vod](/topic/$vod), [$nne](/topic/$nne), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks financial services](/topic/stocks-financial-services), [stocks banks](/topic/stocks-banks), [$erj](/topic/$erj), [stocks industrials](/topic/stocks-industrials), [barclays plc](/topic/barclays-plc), [$argx](/topic/$argx), [$xhs](/topic/$xhs), [$copx](/topic/$copx), [$xes](/topic/$xes), [$cibr](/topic/$cibr), [$speu](/topic/$speu), [stocks technology](/topic/stocks-technology), [coins nft](/topic/coins-nft), [coins base ecosystem](/topic/coins-base-ecosystem), [$otlc](/topic/$otlc), [china](/topic/china), [$biib](/topic/$biib), [biogen inc](/topic/biogen-inc), [$cytk](/topic/$cytk), [canada](/topic/canada), [ras](/topic/ras), [$rvmd](/topic/$rvmd), [$smmt](/topic/$smmt), [$ocgn](/topic/$ocgn), [$cybn](/topic/$cybn), [$cgtx](/topic/$cgtx), [breakthrough](/topic/breakthrough), [$prax](/topic/$prax), [$rhhby](/topic/$rhhby), [$bmy](/topic/$bmy), [$swtx](/topic/$swtx), [$tnxp](/topic/$tnxp), [ip](/topic/ip), [$19m](/topic/$19m), [$kros](/topic/$kros), [$espr](/topic/$espr), [npc](/topic/npc), [$bcab](/topic/$bcab), [summary](/topic/summary), [web3](/topic/web3), [blockchain](/topic/blockchain), [cryptocurrency](/topic/cryptocurrency), [cryptonews](/topic/cryptonews), [ltc](/topic/ltc), [100m](/topic/100m), [#cryptocurrency](/topic/#cryptocurrency), [#crypto](/topic/#crypto), [$mei](/topic/$mei), [$gsr](/topic/$gsr), [$ltc](/topic/$ltc), [$100m](/topic/$100m), [mei pharma](/topic/mei-pharma), [litecoin](/topic/litecoin), [coins pow](/topic/coins-pow), [geysercoin](/topic/geysercoin), [$jazz](/topic/$jazz), [$9926hk](/topic/$9926hk), [tan](/topic/tan), [dia](/topic/dia), [spy](/topic/spy), [$tan](/topic/$tan), [$bjk](/topic/$bjk)

### Top Social Posts [#](/topic/$xph/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$RHHBY Genentech updates on FDA application for Columvi combo for patients with relapsed or refractory Diffuse Large B-cell Lymphoma. More Info: $XBI $IBB $XPH $PPH"  
[@OzmosiHealth](/creator/x/OzmosiHealth) on [X](/post/tweet/1946239716480963035) 2025-07-18 16:04:42 UTC 2418 followers, XXX engagements


"$SWTX European Commission conditionally approves EZMEKLY (mirdametinib) for treating NF1-PN in adult and pediatric patients. More Info: $XBI $IBB $XPH $PPH"  
[@OzmosiHealth](/creator/x/OzmosiHealth) on [X](/post/tweet/1946239709015085116) 2025-07-18 16:04:40 UTC 2418 followers, XXX engagements


"CRYPTODAILY 📰 (Positive🟢) (Important 🌟) "GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee" For AI Summary & More Details 👇 $LTC $GSR $XPH $MEI #cryptonews #crypto #cryptocurrency #cryptocurrencynews #coin #coinnews #blockchain #blockchainnews #news #breaking #defi #web3 #memes #rwa $BTC $ETH $XRP $SOL $BNB #partnership"  
[@CoinHeadlines](/creator/x/CoinHeadlines) on [X](/post/tweet/1946193619511079385) 2025-07-18 13:01:32 UTC XX followers, XX engagements


"$ZVRA Zevra Therapeutics to present MIPLYFFA and OLPRUVA at SERGG Annual Meeting. More Info: $XBI $IBB $XPH $PPH"  
[@OzmosiHealth](/creator/x/OzmosiHealth) on [X](/post/tweet/1946178701269611001) 2025-07-18 12:02:15 UTC 2418 followers, XXX engagements